Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 29, 2016
Patheon has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltd.,...
read more
Thursday, September 05, 2013
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, will be hosting a complimentary seminar on “Robustness, Reproducibility and Risk Management; the Route to Successful...
read more
Patheon announced it expects to invest approximately $45 million at key sites across its global network to meet growing customer demand for expanded service capabilities.
read more
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it continues to implement its corporate transformation strategy across its commercial and pharmaceutical ...
read more
Wednesday, December 23, 2015
Pathline Emerge Pathology Services announced the latest feature expansion of their Clinical Data Exchange capabilities by entering into a definitive agreement with Halfpenny Technologies Inc. The HTI platform will work in conjunction with their ...
read more
Wednesday, November 24, 2021
PathoQuest, a contract research organization (CRO) for the biosafety testing of biologics with Next-Generation Sequencing (NGS) technologies, today announced that it has obtained a Good Manufacturing Practices (GMP) certificate for its quality ...
read more
Wednesday, December 09, 2020
PathoQuest has received support from the Île-de-France region as part of the PM’up Relance Industrie program to accelerate the industrialization of the company’s high value-added service for quality control testing of biologics.
read more
Wednesday, October 27, 2021
PathoQuest, a pioneer in the quality control of biologics using Next-Generation Sequencing (NGS), announced today that it has been awarded €0.85M from the French Investment Program for the Future (Programme d’Investissement d’Avenir - PIA 4). This ...
read more
PathoQuest has received GLP certificate of conformity following a successful inspection by the French National Agency for Medicine and Health Products Safety (ANSM).
read more
Patient identification Platform (Patient iP) announced a new partnership with Aprima Medical Software.
read more
Thursday, October 17, 2019
Crown Bioscience announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the predictivity and speed of preclinical drug discovery.
read more
PatientsLikeMe and Shire have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease.
read more
Wednesday, November 12, 2014
The Pharma & Biopharma Outsourcing Association (PBOA), a new non-profit trade association devoted to advancing the interests of CMOs, CDMOs and other service providers, has elected Peter Bigelow to serve as Chairman of the Board of Trustees.
read more
The PBOA reports its member companies remain committed to serving patients by manufacturing effective, quality products for their customers, during this global health crisis, and report no material disruptions to their operations.
read more
The PBOA reports that many of its member companies are actively involved in helping their clients develop and produce treatments, vaccines, and diagnostics for COVID-19. PBOA’s members provide a wide array of services throughout the bio/pharma sector...
read more